surmount-1 trial tirzepatide weight loss nondiabetic for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity SURMOUNT 1 // Three-Year Obesty

Discovery of the once-weekly GLP-1 analog semaglutide

Another randomized clinical trial is ongoing to assess cardiovascular outcomes in patients with previously established atherosclerotic cardiovascular disease and/or chronic kidney disease treated with oral semaglutide 21

Programs typically require a BMI of at least 2630, especially if there is another chronic disease like type 2 diabetes, sleep apnea, or heart disease

US-manufactured compounds verified at 99%+ purity through third-party HPLC testing with batch-specific Certificates of Analysis

When eating doesnt feel good, you might skip meals, eat very little, wait longer to eat, or reach for bland comfort foods that arent necessarily nutritious